U.S. Banks Stock News

NasdaqGS:ARLP
NasdaqGS:ARLPOil and Gas

Is Alliance Resource Partners (ARLP) Still Attractive After A 7x Five Year Return?

Wondering whether Alliance Resource Partners is offering good value at its current price, or if most of the easy gains are already behind it. The unit price recently closed at US$25.11, with returns of 2.7% over the past week, 7.5% over the past month, 7.8% year to date, a 0.2% decline over the last year, and a gain of 69.2% over three years, while the five year return is very large at roughly 7x. Recent coverage of coal and broader energy markets has focused on shifting demand expectations...
NasdaqGS:AFYA
NasdaqGS:AFYAConsumer Services

Assessing Afya (NasdaqGS:AFYA) Valuation As Shares Trade On A 9.2x P/E And Discounted DCF Price

Afya stock: context for recent performance Afya (NasdaqGS:AFYA) has been on many investors’ radars after a mixed stretch in the share price, with a roughly 2.3% gain over the past day but declines over the past week and month. See our latest analysis for Afya. Zooming out, Afya’s 1 year total shareholder return decline of 10.1% and 5 year total shareholder return decline of 37.9% suggest recent share price momentum has been fading despite the latest move to $13.97. If Afya’s recent swings...
NYSE:MUX
NYSE:MUXMetals and Mining

Is It Too Late To Consider McEwen (MUX) After A 186% One Year Surge

If you are wondering whether McEwen shares still offer value after a strong run, this article walks through what the current price might be implying about the business. The stock last closed at US$23.73, with returns of 6.0% over 7 days, 20.8% over 30 days, 27.0% year to date, 185.9% over 1 year and 230.5% over 3 years, with a 160.8% return across 5 years. Recent coverage around McEwen has focused on the company as investors reassess precious metals exposure and capital allocation across the...
NasdaqGS:NTRA
NasdaqGS:NTRABiotechs

Natera Expands MRD Ambitions With Latitude Study And AI NVIDIA Deal

Natera (NasdaqGS:NTRA) published validation data for its Latitude tissue free molecular residual disease assay in colorectal cancer. The peer reviewed study reports high sensitivity and specificity for colorectal cancer detection and supports regulatory submissions. Natera also announced new multimodal AI powered diagnostics that combine AI with pathology data for its Signatera MRD platform. The company entered a collaboration with NVIDIA focused on accelerating AI model development and...
NasdaqCM:AIRJ
NasdaqCM:AIRJMachinery

AirJoule Technologies (AIRJ) Valuation After ASU A250 Testing Milestone And Ongoing Commercialization Journey

AirJoule Technologies (AIRJ) shares are in focus after the company delivered and commissioned its A250 atmospheric water harvesting system at Arizona State University, kicking off rigorous third-party academic testing. See our latest analysis for AirJoule Technologies. The new ASU deployment and recent equity raise come after a choppy year for investors, with a 90 day share price return of a 31.82% decline and a 1 year total shareholder return of a 58.95% loss. The 1 day move of 8.76% and 7...
NasdaqGS:CTBI
NasdaqGS:CTBIBanks

Community Trust Bancorp (CTBI) EPS Jump Reinforces Bullish Profitability Narrative

Community Trust Bancorp (CTBI) just wrapped up FY 2025 with fourth quarter revenue of US$71.8 million and EPS of US$1.51, capping a twelve month stretch that delivered total revenue of US$270.2 million and EPS of US$5.44. Over the past few quarters, revenue has moved from US$60.0 million in Q3 2024 to US$71.8 million in Q4 2025, while quarterly EPS has shifted from US$1.23 to US$1.51, setting up a year where net income reached US$98.1 million on a trailing basis. With net margins running in...
NasdaqGS:TNYA
NasdaqGS:TNYABiotechs

Tenaya Therapeutics (TNYA) Valuation After 2026 Gene Therapy Updates And US$60 Million Capital Raise

Tenaya Therapeutics (TNYA) is back in focus after updating investors on its heart disease gene therapy programs, outlining 2026 clinical milestones alongside a recent US$60 million capital raise that extends its cash runway. See our latest analysis for Tenaya Therapeutics. At a recent share price of US$0.72, Tenaya’s 1 day share price return of 1.95% follows a 90 day share price return decline of 57.39% and a 1 year total shareholder return decline of 44.07%. This suggests that near term...
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

Is Canaccord’s Endorsement of Clover Health (CLOV) Validate Its Tech-Driven Path to Profitability?

Earlier this week, Canaccord Genuity reiterated its positive view on Clover Health, pointing to the company’s technology-first care model, solid membership growth to about 153,000, rising revenues, and sustained adjusted EBITDA profitability as reasons for confidence in its progress toward profitability. The endorsement underscores how Clover Health’s combination of strong member retention and operational efficiencies is becoming central to its evolving business and financial profile. Next,...
NasdaqGS:VISN
NasdaqGS:VISNCommunications

Is It Too Late To Consider Vistance Networks (VISN) After A 208% One Year Surge?

If you are wondering whether Vistance Networks at US$18.06 is still offering value after a strong run, or if you are late to the story, this breakdown will help you frame that question clearly. The share price has pulled back with a 5.1% decline over the last 7 days and a 1.7% decline over 30 days, even though the 1 year return sits at 208.2% and the 3 year return at 130.4%. Recent coverage has focused on Vistance Networks as a high growth tech name on the Nasdaq and on how its sharp 1 year...
NYSE:HLT
NYSE:HLTHospitality

A Look At Hilton (HLT) Valuation As New Apartment Collection Targets Extended Stay Demand

What Hilton’s new Apartment Collection launch could mean for HLT stock Hilton Worldwide Holdings (HLT) has introduced Apartment Collection by Hilton, a furnished apartment offering launching in major U.S. cities. This development gives investors a fresh angle on how the company is pursuing extended stay and residential style demand. See our latest analysis for Hilton Worldwide Holdings. The new Apartment Collection launch sits alongside other recent moves, including a larger equity buyback...
NasdaqGS:DBX
NasdaqGS:DBXSoftware

Dropbox Valuation Questioned As Competition Rises And Guidance Turns Cautious

Dropbox (NasdaqGS:DBX) is under rising competitive pressure from Microsoft and Google as both rivals expand AI powered productivity and storage tools. The company is experiencing market share losses and AI integration challenges that are weighing on its core file sync and collaboration business. Management has issued negative future guidance, pointing to revenue contraction and no margin expansion for the foreseeable future. These developments are feeding a more bearish outlook on Dropbox's...
NYSE:LBRT
NYSE:LBRTEnergy Services

Is Liberty Energy (LBRT) Pricing Reflect Future Cash Flows After Recent Share Price Rebound

If you are wondering whether Liberty Energy's current share price really reflects what the business is worth, this breakdown is designed to help you size up the stock in a clear and structured way. The share price recently closed at US$21.22, with returns of 5.9% over 7 days, 15.8% over 30 days, 12.4% year to date, a 1.9% decline over 1 year, 47.5% over 3 years and 91.2% over 5 years. Recent coverage around Liberty Energy has focused on its role in the U.S. energy sector and how investors...
NasdaqGS:RGEN
NasdaqGS:RGENLife Sciences

Old National Bancorp Among 3 Value Stocks Priced Below Estimated Worth

As the U.S. stock market rebounds with major indices like the Dow Jones and S&P 500 posting gains, investors are keenly observing opportunities amidst eased geopolitical tensions and stable economic indicators. In this environment, identifying undervalued stocks becomes crucial, as they present potential value by trading below their estimated worth while offering resilience against market fluctuations.
NYSEAM:HYLN
NYSEAM:HYLNElectrical

3 Promising Penny Stocks With Market Caps Below $600M

The U.S. stock market has recently extended its gains, with major indices like the Dow Jones and Nasdaq showing positive momentum amid eased geopolitical tensions. In such a climate, investors often look beyond the well-known giants to explore opportunities in smaller or emerging companies. Penny stocks, though sometimes seen as relics of past market eras, continue to offer intriguing possibilities for those seeking affordability and potential growth. Here, we examine three penny stocks that...
NasdaqGS:ZION
NasdaqGS:ZIONBanks

Zions Bancorporation (ZION) Net Interest Margin Strengthens Bullish Narratives After Q4 Earnings

Zions Bancorporation National Association (ZION) closed out FY 2025 with Q4 revenue of US$885 million and basic EPS of US$1.78, underpinned by net income of US$262 million as the bank reported its latest set of results. The company has seen revenue move from US$779 million and EPS of US$1.34 in Q4 FY 2024 to US$885 million and EPS of US$1.78 in Q4 FY 2025, setting up a story where investors are weighing higher earnings against how sustainable those margins look from here. See our full...
NasdaqGS:AEVA
NasdaqGS:AEVAElectronic

Is Aeva (AEVA) Quietly Reframing Its Investment Story Around Defense Autonomy?

Aeva Technologies announced that Forterra has selected its 4D LiDAR sensors and perception technology to power AutoDrive, Forterra's autonomous defense vehicle system, enhancing obstacle detection and navigation in challenging, GPS-denied environments. This defense-focused win highlights how Aeva’s sensing platform is being applied in mission-critical, high-stakes use cases beyond traditional automotive autonomy. Next, we will assess how this Forterra selection shapes Aeva's investment...
NasdaqGS:FCNC.A
NasdaqGS:FCNC.ABanks

Do Steady Earnings Forecasts Hint At A Mature Phase For First Citizens BancShares' (FCNC.A) Growth Story?

First Citizens BancShares recently announced that it will report its latest quarterly earnings results on Friday morning, following a prior quarter in which it delivered US$2.25 billion of revenue, roughly flat compared with the same period a year earlier. An interesting aspect is that analysts have largely kept their earnings forecasts unchanged over the past month, signaling an expectation of business continuity rather than abrupt change heading into this report. With earnings around the...
NYSE:RNG
NYSE:RNGSoftware

Is There Now An Opportunity In RingCentral (RNG) After Prolonged Share Price Declines

If you are wondering whether RingCentral's current share price still reflects its true value, you are not alone, especially after years of sharp swings in sentiment. The stock closed at US$25.90, with returns of a 10.2% decline over the past week, 12.7% decline over the past month, and 6.1% decline year to date, adding to a 24.0% decline over 1 year and 31.0% decline over 3 years, while the 5 year return sits at a much larger 92.8% decline. These moves have come alongside ongoing investor...
NYSE:PACS
NYSE:PACSHealthcare

A Look At PACS Group (PACS) Valuation After Recent Share Price Volatility

PACS Group stock snapshot after recent performance moves PACS Group (PACS) has drawn fresh attention after a mixed recent performance, with a 1% gain in the latest session alongside a 9% decline over the past week and a month of modest softness. Over the past 3 months, the stock shows a very large total return, while the 1 year total return sits around 156%. Year to date, shares reflect a 9% decline, highlighting meaningful volatility for investors to weigh. See our latest analysis for PACS...
NasdaqGM:TNGX
NasdaqGM:TNGXBiotechs

A Look At Tango Therapeutics (TNGX) Valuation After CEO Transition And Strong Recent Share Price Returns

Tango Therapeutics (TNGX) is in focus after founding CEO and President Dr. Barbara Weber retired, with board member Dr. Malte Peters stepping in as President and CEO, while she transitions to Executive Chair. See our latest analysis for Tango Therapeutics. The leadership change follows a period of strong price momentum, with Tango Therapeutics posting a 45.13% 1‑month share price return and a 66.14% 3‑month share price return, while its 1‑year total shareholder return is just over 3x. If this...